In regard to Lassman et al
- PMID: 22669104
- PMCID: PMC3367856
- DOI: 10.1093/neuonc/nos127
In regard to Lassman et al
Comment on
-
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.Neuro Oncol. 2011 Jun;13(6):649-59. doi: 10.1093/neuonc/nor040. Neuro Oncol. 2011. PMID: 21636710 Free PMC article.
References
-
- Gilbert MR, Lang FF. Anaplastic oligodendroglial tumors: A tale of two trials. J Clin Oncol. 2006;24:2689–2690. doi:10.1200/JCO.2006.05.8594. - DOI - PubMed
-
- Sheline GE, Boldrey E, Karlsberg P, Phillips TL. Therapeutic considerations in tumors affecting the central nervous system: oligodendrogliomas. Radiology. 1964;82:84–89. - PubMed
-
- Lindengaard KF, Mork SJ, Eide, et al. Statistical analysis of clinicopatholical features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg. 1987;67:224–230. doi:10.3171/jns.1987.67.2.0224. - DOI - PubMed
-
- Caincross G, Berkey B, Shaw E, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pre and mixed anaplastic oligodendroglioma: Intergroup Radiotherapy Oncology Group Trial 9402. J Clin Oncol. 2006;24:2707–2714. doi:10.1200/JCO.2005.04.3414. - DOI - PubMed
-
- Van der Bent MJ, Carpentier AF, Shaw E, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic olidendrogliomas and oligoastrocytomas: A randomized European Organization for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006;24:2715–2722. doi:10.1200/JCO.2005.04.6078. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
